Regulus Therapeutics Inc.

NasdaqCM:RGLS

Market Cap

USD 568.41 M

Share Price

USD 8.21

Avg Daily Volume

2,047,107

Change (1 day)

0.12%

Change (1 year)

231.05%

Change (YTD)

419.62%

Regulus Therapeutics Inc. Share Price Year-To-Date (YTD) return on June 18, 2025: 419.62%

Regulus Therapeutics Inc. Share Price Year-To-Date (YTD) return is 419.62% on June 18, 2025. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance. Year-to-Date (YTD) return is is the percentage change in the price of a stock from the start of the calendar year up to the current date, it shows how much the stock has gained or lost since the beginning of the year.
  • Regulus Therapeutics Inc. 52-week low Share Price is USD 8.30 on June 18, 2025, which is 1.10% above the current Share Price.
  • Regulus Therapeutics Inc. 52-week low Share Price is USD 0.97 on June 18, 2025, which is -88.19% below the current Share Price.
  • Regulus Therapeutics Inc. average Share Price for the last 52 weeks is USD 2.48.
Key data
Date Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Price to Book Ratio (P/B) Price to Sales Ratio (P/S)
Market news
Loading...
NasdaqCM: RGLS

Regulus Therapeutics Inc.

CEO Mr. Joseph P. Hagan M.B.A.
IPO Date Oct. 9, 2012
Location United States
Headquarters 4224 Campus Point Court
Employees 34
Sector 🏥 Health Care
Industries
Description

Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Similar companies

NOVO-B.CO

Novo Nordisk A/S

USD 75.07

1.29%

ABBV

AbbVie Inc.

USD 185.49

0.01%

RO.SW

Roche Holding AG

USD 338.56

1.02%

ABT

Abbott Laboratories

USD 132.41

0.10%

NOVN.SW

Novartis AG

USD 116.54

0.69%

AZN.L

AstraZeneca PLC

USD 142.38

0.60%

MRK

Merck & Co., Inc.

USD 79.29

1.29%

AMGN

Amgen Inc.

USD 289.63

-0.14%

PFE

Pfizer Inc.

USD 23.88

-0.50%

GILD

Gilead Sciences, Inc.

USD 108.00

0.00%

SAN.PA

Sanofi

USD 95.53

0.50%

VRTX

Vertex Pharmaceuticals Incorporated

USD 448.40

1.45%

BMY

Bristol-Myers Squibb Company

USD 46.84

-0.83%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 50.10

0.95%

GSK.L

GSK plc

USD 19.35

-0.49%

CSL.AX

CSL Limited

USD 156.33

0.91%

REGN

Regeneron Pharmaceuticals, Inc.

USD 513.58

0.93%

MRK.DE

MERCK Kommanditgesellschaft auf Aktien

USD 125.22

-0.56%

600276.SS

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.17

-0.44%

4502.T

Takeda Pharmaceutical Company Limited

USD 29.64

0.18%

ALNY

Alnylam Pharmaceuticals, Inc.

USD 312.32

1.17%

RGC

Regencell Bioscience Holdings Limited

USD 63.35

-18.78%

UCB.BR

UCB SA

USD 181.20

1.74%

GEHC

GE HealthCare Technologies Inc.

USD 71.89

1.05%

BAYN.DE

Bayer AG

USD 30.95

-0.91%

068270.KS

Celltrion, Inc.

USD 118.94

2.83%

2359.HK

WuXi AppTec Co., Ltd.

USD 9.34

0.31%

LH

Laboratory Corporation of America Holdings

USD 261.39

0.75%

3692.HK

Hansoh Pharmaceutical Group Company Limited

USD 3.54

0.04%

RPRX

Royalty Pharma plc

USD 34.91

1.01%

INSM

Insmed Incorporated

USD 99.46

-0.82%

BIIB

Biogen Inc.

USD 126.54

-0.02%

4503.T

Astellas Pharma Inc.

USD 9.35

0.21%

1801.HK

Innovent Biologics, Inc.

USD 9.71

-2.77%

SMMT

Summit Therapeutics Inc.

USD 20.16

1.56%

4507.T

Shionogi & Co., Ltd.

USD 17.13

0.09%

GMAB.CO

Genmab A/S

USD 215.49

-0.96%

TORNTPHARM.NS

Torrent Pharmaceuticals Limited

USD 36.62

0.37%

NBIX

Neurocrine Biosciences, Inc.

USD 127.31

1.95%

EXEL

Exelixis, Inc.

USD 40.74

-1.50%

MANKIND.NS

Mankind Pharma Limited

USD 26.59

-0.84%

603392.SS

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

USD 8.49

-2.94%

BMRN

BioMarin Pharmaceutical Inc.

USD 55.24

0.44%

ASND

Ascendis Pharma A/S

USD 170.71

-1.27%

9926.HK

Akeso, Inc.

USD 11.52

-1.75%

LUPIN.NS

Lupin Limited

USD 22.27

-0.03%

000963.SZ

Huadong Medicine Co., Ltd

USD 5.73

-0.15%

SOBI.ST

Swedish Orphan Biovitrum AB (publ)

USD 28.19

-3.10%

IPN.PA

Ipsen S.A.

USD 116.31

-0.37%

StockViz Staff

June 21, 2025

Any question? Send us an email